Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTC vs Lamivudine in Stable HIV Patients
NCT00002416Phase 3Completed
- Sponsor
- Triangle Pharmaceuticals, Inc.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of emtricitabine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Triangle Pharmaceuticals, Inc. Primary endpoint: Plasma HIV-1 RNA at 48 weeks. Status: completed.
02
Drugs
emtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002416.